<DOC>
	<DOCNO>NCT02600286</DOCNO>
	<brief_summary>The disease Charcot-Marie-Tooth disease type 1A ( CMT1A ) common inherited peripheral neuropathy , treatment prove effectiveness . It autosomal dominant , associated duplication chromosome 17p11.2 region lead overexpression gene protein-peripheral myelin protein-22 ( PMP22 ) , major component peripheral myelin . In animal human , PMP22 mRNA level glutathione S-transferase theta 2 Cathepsin A ( marker oxidative stress ) , detect skin biopsy marker may play role prognosis evolution disease . Furthermore , several study show administration progesterone increase expression PMP22 gene ( measure skin biopsy ) worsening symptom . In contrast , anti-progestins reduce synthesis PMP22 improve symptom rat CMT1A . The long-term safety anti-progesterone evaluate mifepristone ( RU486 ) ulipristal acetate ( EllaOne® ) . Few side effect report include case endometrial hyperplasia reversible upon discontinuation treatment . With RU486 , rare case adrenal androgen failure observe . However , EllaOne® low antagonistic action glucocorticoid receptor action androgen receptor . The investigator therefore believe well tolerate human reduce synthesis PMP22 action oxidative stress improve disability patient .</brief_summary>
	<brief_title>Ulipristal Acetate In Disease Charcot-Marie-Tooth Type 1A</brief_title>
	<detailed_description />
	<mesh_term>Charcot-Marie-Tooth Disease</mesh_term>
	<mesh_term>Nerve Compression Syndromes</mesh_term>
	<mesh_term>Hereditary Sensory Motor Neuropathy</mesh_term>
	<criteria>Male 1870 year CMT1A proven genetically ( 17p11.2 duplication ) symptomatic CMT1A ( MRC score &lt; 5 least one muscle group ) Non severe axonal impairment ( amplitude motor evoke potential median nerve / ulnar 50 % normal ) Subject contact valid phone number Subject affiliate social security scheme Subject inform result medical examination prior Another cause neuropathy : Chronic alcohol intoxication , chemotherapy , diabetes , kidney failure , monoclonal gammopathy , cryoglobulin , B12 deficiency , hepatitis B / C , HIV , Lyme poliomyelitis Liver failure Lapp lactase deficiency , malabsoprtion syndrome glucose / galactose Support longterm drug interact CYP3A4 Patients indication xylocaine adrenaline In biopsy site : surgery , skin disease local infection Immunosuppression innate acquire Hypersensitivity active substance / excipient uncontrolled severe asthma Treatment vitamin C vitamin B3 four week precede randomization Orthopaedic surgery low limb 6 month prior randomization plan Against indication xylocaine adrenaline Malfunction innate acquire coagulation</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Physical medicine rehabilitation</keyword>
	<keyword>Neurology</keyword>
</DOC>